Current Advances in CAR T Cell Therapy for Malignant Mesothelioma.

Klampatsa, Astero; Albelda, Steven M

Klampatsa, Astero; Albelda, Steven M.

Afiliação

Klampatsa A; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
Albelda SM; Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

J Cell Immunol ; 2(4): 192-200, 2020.

Article em En | MEDLINE | ID: mdl-32914147

Palavras-chave

Adoptive cell transfer; Chimeric antigen receptor T cells; Mesothelioma; Solid tumor; Tumor microenvironment

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480947
https://dx.doi.org/10.33696/immunology.2.042

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480947
https://dx.doi.org/10.33696/immunology.2.042

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article